163 related articles for article (PubMed ID: 11162813)
21. Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.
Quinlivan MA; Gershon AA; Nichols RA; La Russa P; Steinberg SP; Breuer J
J Infect Dis; 2006 Apr; 193(7):927-30. PubMed ID: 16518753
[TBL] [Abstract][Full Text] [Related]
22. Vaccine Oka variants and sequence variability in vaccine-related skin lesions.
Breuer J; Schmid DS
J Infect Dis; 2008 Mar; 197 Suppl 2():S54-7. PubMed ID: 18419409
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of clinical varicella-zoster strains from India and differentiation from the oka vaccine strain.
Kaushik KS; Lahiri KK; Chumber SK; Gupta RM; Kumar S; Kapila K; Karade S
Jpn J Infect Dis; 2008 Jan; 61(1):65-7. PubMed ID: 18219137
[TBL] [Abstract][Full Text] [Related]
24. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
Breuer J; Whitley R
Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
[TBL] [Abstract][Full Text] [Related]
25. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.
Quinlivan M; Gershon AA; Steinberg SP; Breuer J
J Med Virol; 2005 Jan; 75(1):174-80. PubMed ID: 15543576
[TBL] [Abstract][Full Text] [Related]
26. Comparative analyses of the 9 glycoprotein genes found in wild-type and vaccine strains of varicella-zoster virus.
Storlie J; Maresova L; Jackson W; Grose C
J Infect Dis; 2008 Mar; 197 Suppl 2():S49-53. PubMed ID: 18419408
[TBL] [Abstract][Full Text] [Related]
27. The parental strain of the attenuated virus (vOka) used in the varicella vaccine is circulating in China: implications for vaccine surveillance.
Gan L; Wang M; Liu J; Yang S; Chen J
Jpn J Infect Dis; 2010 Mar; 63(2):141-3. PubMed ID: 20332581
[No Abstract] [Full Text] [Related]
28. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
Arvin AM
Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912
[TBL] [Abstract][Full Text] [Related]
29. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.
Ota K; Kim V; Lavi S; Ford-Jones EL; Tipples G; Scolnik D; Tellier R
Pediatr Infect Dis J; 2008 Sep; 27(9):847-8. PubMed ID: 18664930
[TBL] [Abstract][Full Text] [Related]
30. Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand.
Loparev VN; Rubtcova EN; Bostik V; Govil D; Birch CJ; Druce JD; Schmid DS; Croxson MC
J Virol; 2007 Dec; 81(23):12758-65. PubMed ID: 17898056
[TBL] [Abstract][Full Text] [Related]
31. Varicella-zoster virus.
Sheff B
Nursing; 2000 Nov; 30(11):98. PubMed ID: 11111670
[No Abstract] [Full Text] [Related]
32. Use of genomic analysis of varicella-zoster virus to investigate suspected varicella-zoster transmission within a renal unit.
Molyneaux PJ; Parker S; Khan IH; Millar CG; Breuer J
J Clin Virol; 2006 May; 36(1):76-8. PubMed ID: 16545596
[TBL] [Abstract][Full Text] [Related]
33. Reactivation of 2 genetically distinct varicella-zoster viruses in the same individual.
Taha Y; Scott FT; Parker SP; Syndercombe Court D; Quinlivan ML; Breuer J
Clin Infect Dis; 2006 Nov; 43(10):1301-3. PubMed ID: 17051496
[TBL] [Abstract][Full Text] [Related]
34. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
[TBL] [Abstract][Full Text] [Related]
35. Fatal varicella in an immunocompromised adult associated with a European genotype E2 variant of varicella zoster virus.
Springfeld C; Sauerbrei A; Filusch A; Konstandin M; Hartschuh W; Sauer P; Encke J; Stremmel W; Schnitzler P
J Clin Virol; 2009 Jan; 44(1):70-3. PubMed ID: 19056312
[TBL] [Abstract][Full Text] [Related]
36. Immune evasion as a pathogenic mechanism of varicella zoster virus.
Abendroth A; Arvin AM
Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
[TBL] [Abstract][Full Text] [Related]
37. Genomic cartography of varicella-zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences.
Tyler SD; Peters GA; Grose C; Severini A; Gray MJ; Upton C; Tipples GA
Virology; 2007 Mar; 359(2):447-58. PubMed ID: 17069870
[TBL] [Abstract][Full Text] [Related]
38. VZV molecular epidemiology.
Breuer J
Curr Top Microbiol Immunol; 2010; 342():15-42. PubMed ID: 20229231
[TBL] [Abstract][Full Text] [Related]
39. Differentiation between vaccine and wild-type varicella-zoster virus genotypes by high-resolution melt analysis of single nucleotide polymorphisms.
Toi CS; Dwyer DE
J Clin Virol; 2008 Sep; 43(1):18-24. PubMed ID: 18479962
[TBL] [Abstract][Full Text] [Related]
40. On the viral hypothesis of multiple sclerosis: participation of varicella-zoster virus.
Sotelo J
J Neurol Sci; 2007 Nov; 262(1-2):113-6. PubMed ID: 17663004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
